Primary results from ResMed Inc.’s RMD CAT-HF trial showcased the significance of adaptive servo-ventilation (ASV) therapy in the treatment of heart failure (HF). Data were presented at the European ...
- Largest-ever analysis of patients with treatment-emergent central sleep apnea shows switching from CPAP to ASV significantly improves compliance - Study highlights the need to consider therapeutic ...
The US-based but locally-grown ResMed on Wednesday revealed that a clinical trial of its adaptive servo-ventilation (ASV) device had increased, rather than reduced, the risk of death for sufferers of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback